Zemfirza
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Zemfirza, covering 2016-12-21 to 2016-12-21. Get the full timeline:
Most recent: EMA Application withdrawn: Zemfirza (cediranib maleate) — AstraZeneca AB